How many insider declarations has Huntsman Carole filed?

Huntsman Carole has filed 6 public insider declarations with SEC (Form 4).

What is Huntsman Carole's role?

Huntsman Carole's reported role is not specified by the regulator across the filings.

Which companies does Huntsman Carole report trades for?

Huntsman Carole reports trades for Madrigal Pharmaceuticals, INC..

What is Huntsman Carole's declared buy vs sell volume?

Across the available history, declared buys total 0 and disposals 340k€.

← Executives ★ Sign in to follow

HC

Huntsman Carole

US·SEC (Form 4)

Madrigal Pharmaceuticals, INC.

Cumul. flow

0

Total declarations

0

Company

—

▲ Purchases (0 ops.)

€339,776

▼ Sales (3 ops.)

Insider track record

Other

Disclosed buys

0

Disclosed sells

3

Not enough buy signals with a settled T+90 horizon to measure a track record yet.

Signal history

Explore the detailed record of transactions filed by Huntsman Carole. Director active across 1 company, notably Madrigal Pharmaceuticals, INC.. Aggregated, 6 filings have been published. Split: 0 buy · 3 sells. Total volume traded: €340k. History available since 20 November 2023. The latest transaction was filed on 5 March 2025 (Attribution). Regulator: SEC (Form 4). The full history is free.

Declarations6 total

◆

Huntsman Carole

Chief Commercial OfficerExecutives5 Mar 2025Madrigal Pharmaceuticals, INC.

11SEC ↗

3,386 shares0Common StockSEC:0001628280-25-011321:0

▼

Huntsman Carole

Chief Commercial OfficerExecutives3 Mar 2025Madrigal Pharmaceuticals, INC.

$22,22930SEC ↗

71 shares@ US$313.086.3% of flowCommon StockSEC:0001628280-25-010492:0

▼